ACRV vs IQST Comparison

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

iQSTEL Inc is a technology company offering a wide array of services to the telecom and Internet industry. The business divisions of the company are Telecommunication including VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform; the Fintech division includes remittances services, top-up services, Master Card Debit Card, a USA Bank Account, and a Mobile App; Electric Vehicles division offers Electric Motorcycles and plans to launch a Mid Speed Car; and the Metaverse division includes Metaverse platform to access products, services, content, entertainment, information, customer support, and more in a virtual 3D interface. Geographically, it derives a majority of its revenue from the USA.